MedTrace Logo

Use of Penthrox in Extra-hospital Traumatology

NCT03537001 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2019-04-24

No results posted yet for this study

Summary

In pre-hospital settings, the administration of analgesics is often delayed because of difficult patient access (incarceration), difficulty finding a venous pathway or patient refusal.

An optimization of the management of pain in urgency is therefore still necessary.

A side from nitrousoxide of which usage remains restrictive, methoxyflurane (Penthrox®) is the only volatile analgesic currently available for pre-hospital use.

The purpose of this study is to answer the question: Does the use of the inhaled route with Penthrox add value to the treatment of acute traumatic pain in the pre-hospital stage?

Conditions

  • Pain, Acute
  • Trauma Injury
  • Pain Management

Interventions

OTHER

Penthrox

Self-administration of penthrox by the patient under the supervision of a physician trained in its administration, in strict compliance with its MA.

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-29
Primary Completion
2018-08-30
Completion
2018-08-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03537001 on ClinicalTrials.gov